Safety of generic fingolimod
Generic drug of fingolimode (Nesklair, Russia) receives marketing authorisation in 2014. In 2016, was initiated the Post-authorisation safety study (PASS) to evaluate the safety of Neskler in patients with remitting multiple sclerosis (MS) vs. original drug and in the primary assignment. This PASS w...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-03-01
|
| Serie: | Безопасность и риск фармакотерапии |
| Soggetti: | |
| Accesso online: | https://www.risksafety.ru/jour/article/view/96 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|